Bulletin of the World Health Organization

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

Yoel Lubell, Arthorn Riewpaiboon, Arjen M Dondorp, Lorenz von Seidlein, Olugbenga A Mokuolu, Margaret Nansumba, Samwel Gesase, Alison Kent, George Mtove, Rasaq Olaosebikan, Wirichada Pan Ngum, Caterina I Fanello, Ilse Hendriksen, Nicholas PJ Day, Nicholas J White & Shunmay Yeung

Volume 89, Number 7, July 2011, 504-512

Table 1. Sites included in the African Quinine Artesunate Malaria Treatment trial

Sitea Region of Africa Malaria endemicity Hospital level
Korogwe, United Republic of Tanzania Eastern Endemic and perennial with seasonal peaks/Low Primary (district hospital)
Teule, United Republic of Tanzania Eastern Endemic and perennial with seasonal peaks/High Secondary (district hospital)
Mbarara, Uganda Eastern/Central Endemic and perennial with seasonal peaks/High Tertiary
Ilorin, Nigeria Western Endemic and perennial with seasonal peaks/High Tertiary
Mozambique Southern Endemic and perennial with seasonal peaks/High Tertiary
Gambia Western Endemic with seasonal transmission/High Tertiary
Ghana Western Endemic and perennial with seasonal peaks/High Tertiary
Kenya Eastern Endemic and perennial with seasonal peaks/Low Secondary (district hospital)
Rwamagana, Rwanda Eastern Endemic and perennial with seasonal peaks/Low Secondary (district hospital)
Niyanza, Rwanda Eastern Endemic and perennial with seasonal peaks/Low Secondary (district hospital)
Democratic Republic of the Congo Central Endemic and perennial with seasonal peaks/High Secondary (district hospital)

a The top four sites were included in the costing analysis.